In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus
Identifieur interne : 001075 ( Main/Exploration ); précédent : 001074; suivant : 001076In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus
Auteurs : L. Cegolon [Italie, Royaume-Uni] ; C. Salata [Italie] ; E. Piccoli [Italie] ; V. Juarez [France] ; G. Palu' [Italie] ; G. Mastrangelo [Italie] ; A. Calistri [Italie]Source :
- International journal of hygiene and environmental health [ 1438-4639 ] ; 2014.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Santé publique.
English descriptors
- KwdEn :
Abstract
Influenza virus spreads via small particle aerosols, droplets and fomites, and since it can survive for a short time on surfaces, can be introduced into the nasal mucosa before it loses infectivity. The hypothiocyanite ion (OSCN-), product of the lactoperoxidase/H2O2/SCN- system of central airways, is emerging as an important molecule for innate defense mechanism against bacteria, fungi and viruses. Here we demonstrated that OSCN- displays virucidal activity in vitro against the A/H1N1 2009 pandemic influenza virus. The concentration required to inhibit viral replication by 50% was 2 μM when virus were challenged directly with OSCN- before cell inoculation. These values were even lower when inoculated cells were maintained in contact with enzyme free-OSCN- in the culture medium. The last experimental conditions better reflect those of tracheobronchial mucosa, where HOSCN/OSCN- is retained in the air-liquid interface and inactivates both the viruses approaching the epithelium from outside and those released from the inoculated cells after the replication cycle. Importantly no OSCN- cytotoxicity was observed in the cellular system employed. The lack of toxicity in humans and the absence of damage on surfaces of fomites suggest a potential use of OSCN- to avoid mucosal and environmental transmission of influenza virus. Since hypothiocyanite is normally present in human airways a low risk of viral resistance is envisaged. In vivo confirmatory studies are needed to evaluate the appropriate dose, regimen and formulation.
Affiliations:
- France, Italie, Royaume-Uni
- Angleterre, Auvergne-Rhône-Alpes, Grand Londres, Rhône-Alpes
- Londres, Lyon
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000145
- to stream PascalFrancis, to step Curation: 001C73
- to stream PascalFrancis, to step Checkpoint: 000084
- to stream Main, to step Merge: 001085
- to stream Main, to step Curation: 001075
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus</title>
<author><name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Imperial College London, School of Public Health, St. Mary's Campus</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Alaxia SAS</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0075821</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0075821 INIST</idno>
<idno type="RBID">Pascal:14-0075821</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000145</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001C73</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000084</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000084</idno>
<idno type="wicri:doubleKey">1438-4639:2014:Cegolon L:in:vitro:antiviral</idno>
<idno type="wicri:Area/Main/Merge">001085</idno>
<idno type="wicri:Area/Main/Curation">001075</idno>
<idno type="wicri:Area/Main/Exploration">001075</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus</title>
<author><name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Imperial College London, School of Public Health, St. Mary's Campus</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Alaxia SAS</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">International journal of hygiene and environmental health</title>
<title level="j" type="abbreviated">Int. j. hyg. environ. health : (print)</title>
<idno type="ISSN">1438-4639</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of hygiene and environmental health</title>
<title level="j" type="abbreviated">Int. j. hyg. environ. health : (print)</title>
<idno type="ISSN">1438-4639</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>2009</term>
<term>Antiviral</term>
<term>Biological activity</term>
<term>Check</term>
<term>Disinfection</term>
<term>Environmental medicine</term>
<term>H1N1 influenza</term>
<term>Health and environment</term>
<term>In vitro</term>
<term>Infection</term>
<term>Influenzavirus</term>
<term>Prevention</term>
<term>Public health</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Infection</term>
<term>Activité biologique</term>
<term>In vitro</term>
<term>Antiviral</term>
<term>2009</term>
<term>Santé publique</term>
<term>Influenzavirus</term>
<term>Prévention</term>
<term>Traitement</term>
<term>Contrôle</term>
<term>Désinfection</term>
<term>Santé et environnement</term>
<term>Médecine environnementale</term>
<term>Pandémie</term>
<term>Grippe H1N1</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Santé publique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Influenza virus spreads via small particle aerosols, droplets and fomites, and since it can survive for a short time on surfaces, can be introduced into the nasal mucosa before it loses infectivity. The hypothiocyanite ion (OSCN<sup>-</sup>
), product of the lactoperoxidase/H<sub>2</sub>
O<sub>2/</sub>
SCN<sup>-</sup>
system of central airways, is emerging as an important molecule for innate defense mechanism against bacteria, fungi and viruses. Here we demonstrated that OSCN<sup>-</sup>
displays virucidal activity in vitro against the A/H1N1 2009 pandemic influenza virus. The concentration required to inhibit viral replication by 50% was 2 μM when virus were challenged directly with OSCN<sup>-</sup>
before cell inoculation. These values were even lower when inoculated cells were maintained in contact with enzyme free-OSCN<sup>-</sup>
in the culture medium. The last experimental conditions better reflect those of tracheobronchial mucosa, where HOSCN/OSCN<sup>-</sup>
is retained in the air-liquid interface and inactivates both the viruses approaching the epithelium from outside and those released from the inoculated cells after the replication cycle. Importantly no OSCN<sup>-</sup>
cytotoxicity was observed in the cellular system employed. The lack of toxicity in humans and the absence of damage on surfaces of fomites suggest a potential use of OSCN<sup>-</sup>
to avoid mucosal and environmental transmission of influenza virus. Since hypothiocyanite is normally present in human airways a low risk of viral resistance is envisaged. In vivo confirmatory studies are needed to evaluate the appropriate dose, regimen and formulation.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
<li>Italie</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Grand Londres</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Londres</li>
<li>Lyon</li>
</settlement>
</list>
<tree><country name="Italie"><noRegion><name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
</noRegion>
<name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
</region>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001075 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001075 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:14-0075821 |texte= In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus }}
![]() | This area was generated with Dilib version V0.6.34. | ![]() |